Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (177)

« Back to Publications

Blood biomarkers to improve dementia diagnostic accuracy: a cross-sectional analysis.

Kwon J. et al, (2026), BMC Geriatr

Causal inference in real-world dementia research: a systematic review protocol.

Yang Y. et al, (2026), Syst Rev

Lecanemab appropriate use recommendations for clinical practice in the UK.

Mummery CJ. et al, (2026), J Neurol Neurosurg Psychiatry, 97, 372 - 384

Neuropsychiatric Symptoms and Caregiver Distress at Diagnostic Assessment for Suspected Memory Disorders: Evidence from the Oxford Brain Health Clinic

Du J. et al, (2026)

Alzheimer's disease and memantine effects on NMDA-receptor blockade: non-invasive in vivo insights from magnetoencephalography.

Lanskey JH. et al, (2026), Mol Psychiatry, 31, 1587 - 1596

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.

Demnitz-King H. et al, (2026), Nat Rev Neurol, 22, 123 - 135

Blood biomarkers for diagnosis and differential diagnosis of Alzheimer's disease in real-world clinical populations: A systematic review.

Suresh S. et al, (2026), J Alzheimers Dis, 109, 1574 - 1589

Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED).

Qin H. et al, (2026), Alzheimers Dement, 22

Divergence of cortical neurophysiology across different neurodegenerative disorders compared to healthy ageing.

Trubshaw M. et al, (2026), Prog Neurobiol, 257

Digital cognition plus plasma p-Tau217 and Aβ42/40 powerfully predict Alzheimer's progression.

Begde A. et al, (2026), Alzheimers Dement (Amst), 18

Public Health.

Gillis G. et al, (2025), Alzheimers Dement, 21 Suppl 6

Dementia Care Research and Psychosocial Factors.

DU J. et al, (2025), Alzheimers Dement, 21 Suppl 4

Alzheimer's Imaging Consortium.

Gillis G. et al, (2025), Alzheimers Dement, 21 Suppl 8

Biomarkers

Krugliak A. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Drug Development

Iqbal S. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Load More

1
2
3
4
5
6
7
...
»